Yinghui Tong

3PUBLICATIONS
1CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 29, 2021
Cost-effectiveness analysis of durvalumab plus etoposide: platinum in the first-line therapy of extensive stage small-cell lung cancer from the Chinese payers' perspective.

Ying-Hui Tong, Hai-Ying Ding, Wen-Xiu Xin

|Dec 29, 2020
Cost-effectiveness of pembrolizumab for treatment of platinum-resistant recurrent or metastatic head and neck squamous cell carcinoma in China: an economic analysis based on a randomised, open-label, phase III trial.

Wenxiu Xin, Haiying Ding, Qilu Fang

|Sep 04, 2019
Elevated proportion of collapsed microvessels indicate poor survival outcome in patients with non-small cell lung cancer.

Ying-Hui Tong, Ying He, Lu-Ying Hu

Pageof 1

Frequent Collaborators

1 joint publications

Wenxiu Xin